Price is syncing
Reported smart-money activity is still available below.
1 month
+3.2%
price return
Year to date
+9.1%
price return
Recent earnings
1/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
16 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage is bullish
9 bullish · 6 neutral · 1 bearish
Tone of tracked coverage
Spruce Street Capital LP Raises Stock Holdings in Dianthus Therapeutics, Inc. $DNTH
Leans bullishJul 25Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Average Rating of "Moderate Buy" from Analysts
BullishJul 25Walleye Capital LLC Has $12.89 Million Position in Dianthus Therapeutics, Inc. $DNTH
NeutralJul 24Wedbush Maintains Dianthus Therapeutics (DNTH) Outperform Recommendation
BullishJul 20Dianthus Therapeutics Stock Surges After Initiating Major Phase 3 Clinical Trial
BullishJul 20Enterprise value to EBITDA forward of Dianthus Therapeutics, Inc. – FWB:87E
NeutralJul 20Dianthus Therapeutics, Inc. (DNTH) reports Q1 loss, lags revenue estimates
NeutralJul 18Dianthus Therapeutics DNTH Jumps As Phase 3 EMERGE Trial Kicks Off
BullishJul 17BlackRock
Q1 2026 13F
$266.5M
position
AlphaYou
